These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 24776783)
1. Safety and efficacy of oxandrolone in growth hormone-treated girls with Turner syndrome: evidence from recent studies and recommendations for use. Sas TC; Gault EJ; Bardsley MZ; Menke LA; Freriks K; Perry RJ; Otten BJ; de Muinck Keizer-Schrama SM; Timmers H; Wit JM; Ross JL; Donaldson MD Horm Res Paediatr; 2014; 81(5):289-97. PubMed ID: 24776783 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome. Menke LA; Sas TC; de Muinck Keizer-Schrama SM; Zandwijken GR; de Ridder MA; Odink RJ; Jansen M; Delemarre-van de Waal HA; Stokvis-Brantsma WH; Waelkens JJ; Westerlaken C; Reeser HM; van Trotsenburg AS; Gevers EF; van Buuren S; Dejonckere PH; Hokken-Koelega AC; Otten BJ; Wit JM J Clin Endocrinol Metab; 2010 Mar; 95(3):1151-60. PubMed ID: 20061421 [TBL] [Abstract][Full Text] [Related]
3. Prospective study confirms oxandrolone-associated improvement in height in growth hormone-treated adolescent girls with Turner syndrome. Zeger MP; Shah K; Kowal K; Cutler GB; Kushner H; Ross JL Horm Res Paediatr; 2011; 75(1):38-46. PubMed ID: 20733274 [TBL] [Abstract][Full Text] [Related]
4. The effect of the weak androgen oxandrolone on psychological and behavioral characteristics in growth hormone-treated girls with Turner syndrome. Menke LA; Sas TC; Visser M; Kreukels BP; Stijnen T; Zandwijken GR; de Muinck Keizer-Schrama SM; Otten BJ; Wit JM; Cohen-Kettenis PT Horm Behav; 2010 Mar; 57(3):297-305. PubMed ID: 20053349 [TBL] [Abstract][Full Text] [Related]
5. Long-term effects of previous oxandrolone treatment in adult women with Turner syndrome. Freriks K; Sas TC; Traas MA; Netea-Maier RT; den Heijer M; Hermus AR; Wit JM; van Alfen-van der Velden JA; Otten BJ; de Muinck Keizer-Schrama SM; Gotthardt M; Dejonckere PH; Zandwijken GR; Menke LA; Timmers HJ Eur J Endocrinol; 2013 Jan; 168(1):91-9. PubMed ID: 23076845 [TBL] [Abstract][Full Text] [Related]
6. Oxandrolone for growth hormone-treated girls aged up to 18 years with Turner syndrome. Mohamed S; Alkofide H; Adi YA; Amer YS; AlFaleh K Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684688 [TBL] [Abstract][Full Text] [Related]
7. The effect of oxandrolone on voice frequency in growth hormone-treated girls with Turner syndrome. Menke LA; Sas TC; van Koningsbrugge SH; de Ridder MA; Zandwijken GR; Boersma B; Dejonckere PH; de Muinck Keizer-Schrama SM; Otten BJ; Wit JM J Voice; 2011 Sep; 25(5):602-10. PubMed ID: 20971614 [TBL] [Abstract][Full Text] [Related]
8. Favorable final height outcome in girls with Ullrich-Turner syndrome treated with low-dose growth hormone together with oxandrolone despite starting treatment after 10 years of age. Stahnke N; Keller E; Landy H; J Pediatr Endocrinol Metab; 2002 Feb; 15(2):129-38. PubMed ID: 11874177 [TBL] [Abstract][Full Text] [Related]
9. Comments on 'Prospective study confirms oxandrolone-associated improvement in height in growth hormone-treated adolescent girls with Turner syndrome' by Zeger et al., pp. 39-47, this issue. Menke LA; Sas TC; Wit JM Horm Res Paediatr; 2011; 75(1):47-8. PubMed ID: 21051854 [No Abstract] [Full Text] [Related]
10. The effect of oxandrolone on body proportions and body composition in growth hormone-treated girls with Turner syndrome. Menke LA; Sas TC; Zandwijken GR; de Ridder MA; Stijnen T; de Muinck Keizer-Schrama SM; Otten BJ; Wit JM Clin Endocrinol (Oxf); 2010 Aug; 73(2):212-9. PubMed ID: 20105186 [TBL] [Abstract][Full Text] [Related]
11. Influence of hormonal therapy on growth rate and bone age progression in patients with Turner syndrome. Gawlik A; Gawlik T; Koehler B; Malecka-Tendera E; Augustyn M; Woska W Endokrynol Pol; 2005; 56(2):136-44. PubMed ID: 16335681 [TBL] [Abstract][Full Text] [Related]
12. Effect of oxandrolone on glucose metabolism in growth hormone-treated girls with Turner syndrome. Menke LA; Sas TC; Stijnen T; Zandwijken GR; de Muinck Keizer-Schrama SM; Otten BJ; Wit JM Horm Res Paediatr; 2011 Feb; 75(2):115-22. PubMed ID: 20814189 [TBL] [Abstract][Full Text] [Related]
13. [Carbohydrate metabolism in patients with Turner syndrome. The effect of therapy with growth hormone, oxandrolone and a combination of both]. Starzyk J Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(2):79-84. PubMed ID: 15996336 [TBL] [Abstract][Full Text] [Related]
14. Effect of oxandrolone and timing of oral ethinylestradiol initiation on pubertal progression, height velocity and bone maturation in the UK Turner study. Perry RJ; Gault EJ; Paterson WF; Dunger DB; Donaldson MD Horm Res Paediatr; 2014; 81(5):298-308. PubMed ID: 24751470 [TBL] [Abstract][Full Text] [Related]